药明生物：陈智胜减持，好仓比例降至1.47%

港股披露09-17 17:41

陈智胜于2026年9月11日在联交所场内以每股均价49.1359港元卖出药明生物股份120.00万股，涉资约5896.31万港元，属场内主动交易，即在二级市场直接买卖股份。该笔卖出源于陈智胜依据公司首次公开发售前购股权计划行使购股权后所得股份的出售，以满足税务等负债。

陈智胜此次减持前持有药明生物好仓6218.11万股，占比1.5%；减持后持股量为6098.11万股，好仓比例降至1.47%。

原文链接：Hong Kong Exchanges and Clearing Limited

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/1188559283?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-09-17 17:41","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188559283","market":"hk","top_or_hot":-1,"title":"药明生物：陈智胜减持，好仓比例降至1.47%","media":"港股披露","content":"<p><p>陈智胜于2026年9月11日在联交所场内以每股均价49.1359港元卖出药明生物股份120.00万股，涉资约5896.31万港元，属场内主动交易，即在二级市场直接买卖股份。该笔卖出源于陈智胜依据公司首次公开发售前购股权计划行使购股权后所得股份的出售，以满足税务等负债。</p><p>陈智胜此次减持前持有药明生物好仓6218.11万股，占比1.5%；减持后持股量为6098.11万股，好仓比例降至1.47%。</p><p>原文链接：<a href=\"https://sc.hkexnews.hk/TuniS/di.hkex.com.hk/di/NSForm3A.aspx?fn=DA20260916E00540&sa2=ns&sid=174136&sd=17/09/2025&ed=17/09/2026&sa1=cl&scsd=17/09/2025&sced=17/09/2026&sc=02269&src=Main&lang=ZH&tk=ds\" target=\"_blank\">Hong Kong Exchanges and Clearing Limited</a></p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>药明生物：陈智胜减持，好仓比例降至1.47%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n药明生物：陈智胜减持，好仓比例降至1.47%\n</h2>\n\n<h4 class=\"meta\">\n\n2026-09-17 17:41 北京时间&nbsp;&nbsp;&nbsp;<strong>港股披露</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>陈智胜于2026年9月11日在联交所场内以每股均价49.1359港元卖出药明生物股份120.00万股，涉资约5896.31万港元，属场内主动交易，即在二级市场直接买卖股份。该笔卖出源于陈智胜依据公司首次公开发售前购股权计划行使购股权后所得股份的出售，以满足税务等负债。陈智胜此次减持前持有药明生物好仓6218.11万股，占比1.5%；减持后持股量为6098.11万股，好仓比例降至1.47%。原文链接...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02269","symbol_name":"药明生物","start_time":0,"source_url":"","article_id":"1188559283","we_media_id":"1078898823","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188559283","pubTimestamp":1789638099,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"港股披露","introduction":"追踪最新港股股权披露信息。","home_visible":1,"id":"1078898823","head_image":"https://community-static.tradeup.com/news/a632f2fd508536f86d1ef761a603574c"},"summary":"陈智胜于2026年9月11日在联交所场内以每股均价49.1359港元卖出药明生物股份120.00万股，涉资约5896.31万港元，属场内主动交易，即在二级市场直接买卖股份。该笔卖出源于陈智胜依据公司首次公开发售前购股权计划行使购股权后所得股份的出售，以满足税务等负债。陈智胜此次减持前持有药明生物好仓6218.11万股，占比1.5%；减持后持股量为6098.11万股，好仓比例降至1.47%。原文链接：Hong Kong Exchanges and Clearing Limited","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02269":"药明生物"},"translate_title":"WuXi Biologics: Chen Zhisheng reduces holdings, long position ratio drops to 1.47%","themeId":"f7700173111443e192ac74957e46cb69","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02269":1},"content_text":"陈智胜于2026年9月11日在联交所场内以每股均价49.1359港元卖出药明生物股份120.00万股，涉资约5896.31万港元，属场内主动交易，即在二级市场直接买卖股份。该笔卖出源于陈智胜依据公司首次公开发售前购股权计划行使购股权后所得股份的出售，以满足税务等负债。陈智胜此次减持前持有药明生物好仓6218.11万股，占比1.5%；减持后持股量为6098.11万股，好仓比例降至1.47%。原文链接：Hong Kong Exchanges and Clearing Limited","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.0","shortVersion":"4.50.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1188559283","isCrawlerRequest":true}